Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration.
about
Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye DiseaseMacular pigment in retinal health and diseaseLutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular diseaseLutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.Lutein, zeaxanthin and meso-zeaxanthin content of eggs laid by hens supplemented with free and esterified xanthophyllsCognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent CarotenoidsSerum and macular response to carotenoid-enriched egg supplementation in human subjects: the Egg Xanthophyll Intervention clinical Trial (EXIT)Mechanisms of selective delivery of xanthophylls to retinal pigment epithelial cells by human lipoproteins.Non-Dietary Correlates and Determinants of Plasma Lutein and Zeaxanthin Concentrations in the Irish Population.Increased Macular Pigment Optical Density and Visual Acuity following Consumption of a Buttermilk Drink Containing Lutein-Enriched Egg Yolks: A Randomized, Double-Blind, Placebo-Controlled Trial.Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations.Lutein, zeaxanthin and mammalian development: Metabolism, functions and implications for health.Comparison of macular pigment and serum lutein concentration changes between free lutein and lutein esters supplements in Japanese subjects.
P2860
Q26773085-CA292A9F-C26C-4729-B002-632FF08F7BC3Q28072398-A97CF6E9-F922-4285-B311-CF01EFFA4271Q30693939-C7AD68CB-2CF8-4EE2-84B1-C4530B4B02EAQ36078526-ECBE637E-DE4B-4434-AA3D-62FCA02258E7Q36454134-C006DB62-68E3-493F-92F0-E09FE9251AF8Q37044220-CE45D30F-5193-4560-9B70-C62D32C80544Q37631347-2CD6522C-04E0-4736-BF7F-FF064A5DAF0EQ38751193-36FC5B83-1FEF-425B-B149-8D3F73970D68Q38937657-C55A73BE-8B26-46E3-A030-C84D84CD5504Q39533399-3B0D4DE3-CB5B-4513-8DA9-ACCBAA6C0F9BQ46100951-EDFBAFB0-1FCC-4B5C-8607-DC754BF9218CQ52588804-B430760F-F235-4F94-83D2-FC765A47557CQ54591303-1BCCE114-5DD8-4269-9641-D7D750A3D8AB
P2860
Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Macular response to supplement ...... -related macular degeneration.
@ast
Macular response to supplement ...... -related macular degeneration.
@en
Macular response to supplement ...... -related macular degeneration.
@nl
type
label
Macular response to supplement ...... -related macular degeneration.
@ast
Macular response to supplement ...... -related macular degeneration.
@en
Macular response to supplement ...... -related macular degeneration.
@nl
prefLabel
Macular response to supplement ...... -related macular degeneration.
@ast
Macular response to supplement ...... -related macular degeneration.
@en
Macular response to supplement ...... -related macular degeneration.
@nl
P2093
P2860
P1476
Macular response to supplement ...... -related macular degeneration.
@en
P2093
Alan N Howard
David I Thurnham
Stephen Beatty
P2860
P2888
P304
P356
10.1007/S00417-014-2811-3
P50
P577
2014-10-14T00:00:00Z
P6179
1039871315